Literature DB >> 1384667

Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism.

M H Jones1, Y Nakamura.   

Abstract

Loss of heterozygosity at the TP53 locus occurs frequently in many types of cancer and requires polymorphic markers for detection. Several polymorphisms at the TP53 locus have been described previously, and polymerase chain reaction (PCR)-based assays have been developed to detect these polymorphisms. However, these polymorphisms have relatively low levels of heterozygosity and are often uninformative. We report here the detection of loss of heterozygosity at the TP53 locus in various human cancers by using a highly informative dinucleotide repeat polymorphism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384667     DOI: 10.1002/gcc.2870050113

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  46 in total

1.  Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin.

Authors:  Z P Ren; A Ahmadian; F Pontén; M Nistér; C Berg; J Lundeberg; M Uhlén; J Pontén
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi-automated fluorescence-based detection: subregional mapping of chromosome 4 in cervical carcinoma.

Authors:  G M Hampton; A A Larson; R N Baergen; R L Sommers; S Kern; W K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  Bcl-2 expression and allelic loss of the p53 gene in gastric carcinomas.

Authors:  M Saegusa; Y Takano; Y Kamata; J Okayasu
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

4.  Feasibility of a cost-effective approach to evaluate short tandem repeat markers suitable for chimerism follow-up.

Authors:  Ariela F Fundia; Carlos De Brasi; Irene Larripa
Journal:  Mol Diagn       Date:  2004

5.  Allelic loss at TP53 in metastatic human endometrial carcinomas.

Authors:  Wiktor Szewczuk; Danuta Skomra; Marek Cybulski; Dorota Przadka-Rabaniuk; Agata Filip; Maciej Jóźwik; Piotr Olcha; Albert Roessner; Andrzej Semczuk
Journal:  Clin Exp Metastasis       Date:  2009-06-30       Impact factor: 5.150

6.  An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53.

Authors:  J M Varley; G McGown; M Thorncroft; K J Tricker; M D Teare; M F Santibanez-Koref; J Martin; J M Birch; D G Evans
Journal:  J Med Genet       Date:  1995-12       Impact factor: 6.318

7.  Cell lines from non-neoplastic liver and hepatocellular carcinoma tissue from a single patient.

Authors:  M Noguchi; S Hirohashi
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-03       Impact factor: 2.416

8.  Molecular damage in the bronchial epithelium of current and former smokers.

Authors:  I I Wistuba; S Lam; C Behrens; A K Virmani; K M Fong; J LeRiche; J M Samet; S Srivastava; J D Minna; A F Gazdar
Journal:  J Natl Cancer Inst       Date:  1997-09-17       Impact factor: 13.506

9.  Loss of heterozygosity analysis of chromosome 17p13.1-13.3 and its correlation with clinical outcome in medulloblastomas.

Authors:  Hye Lim Jung; Kyu-Chang Wang; Seung-Ki Kim; Ki Woong Sung; Hong Hoe Koo; Hee Young Shin; Hyo Seop Ahn; Hyung Jin Shin; Byung-Kyu Cho
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

10.  Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours.

Authors:  P A Crossey; K Foster; F M Richards; M E Phipps; F Latif; K Tory; M H Jones; E Bentley; R Kumar; M I Lerman
Journal:  Hum Genet       Date:  1994-01       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.